MANNING & NAPIER GROUP, LLC – BioMarin Pharmaceutical Inc. Transaction History
MANNING & NAPIER GROUP, LLC portfolio value:
$78.98M
portfolio value
MANNING & NAPIER GROUP, LLC quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.54% | -14.61K shares | 560K | $84.77 | 931.79K |
Q2 2022 | share | Decrease | -44.50% | -758.95K shares | -53.05M | $82.87 | 946.40K |
Q1 2022 | share | Decrease | -1.83% | -31.70K shares | -21.98M | $77.1 | 1.70M |
Q4 2021 | share | Decrease | -0.34% | -5.92K shares | 18.75M | $89.08 | 1.73M |
Q3 2021 | share | Increase | +0.90% | 15.59K shares | -9.41M | $77.29 | 1.74M |
Q2 2021 | share | Increase | +1.32% | 22.54K shares | 15.4M | $83.44 | 1.72M |
Q1 2021 | share | Increase | +57.37% | 621.48K shares | 33.73M | $75.51 | 1.70M |
Q4 2020 | share | Decrease | -4.36% | -49.35K shares | 8.82M | $87.69 | 1.08M |
Q3 2020 | share | Increase | +16.71% | 162.19K shares | -33.52M | $76.08 | 1.13M |
Q2 2020 | share | Decrease | -7.60% | -79.83K shares | 30.94M | $123.34 | 970.52K |
Q1 2020 | share | Decrease | -4.53% | -49.83K shares | -4.26M | $84.5 | 1.05M |
Q4 2019 | share | Increase | +50.69% | 370.09K shares | 43.81M | $84.55 | 1.10M |
Q3 2019 | share | Increase | +0.56% | 4.03K shares | -12.97M | $67.4 | 730.09K |
Q2 2019 | share | Decrease | -20.30% | -184.89K shares | -18.73M | $85.65 | 726.06K |
Q1 2019 | share | Decrease | -8.90% | -88.95K shares | -4.22M | $88.83 | 910.95K |
Q4 2018 | share | Decrease | -28.81% | -404.61K shares | -51.05M | $85.15 | 999.91K |
Q3 2018 | share | Decrease | -25.44% | -479.14K shares | -41.24M | $96.97 | 1.40M |
Q2 2018 | share | Decrease | -1.71% | -32.78K shares | 22.07M | $94.2 | 1.88M |
Q1 2018 | share | Decrease | -3.25% | -64.41K shares | -21.26M | $81.07 | 1.91M |
Q4 2017 | share | Increase | 0.00% | 1.98M shares | 176.63M | $89.17 | 1.98M |